Business News

AbbVie dives deeper into eye care, paying $370M cash — with a $1.4B sweetener — to partner on VEGF gene therapy – Endpoints News

Frederick “Fred” Frank, legendary investment banker and biotech giant who reshaped the structure of the biopharma industry by brokering such influential deals as Roche’s initial purchase of Genentech stock in 1990, passed away over the weekend.

Click here to view the original article.

Related Posts

You might also like ...